BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pancreas
,
Amniocentesis
,
Ciprofibrate
,
rs2476601
,
IGF1
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
thymic lymphomas
Summary
General Info
Curated Studies
Most Correlated Studies
Thymic lymphomas from p53 mutant (R270H) mice with varying HIF levels
Thymic lymphoma T29 cells, Ikaros deficient, treated with G-secretase inhibitor (MRK003)
Thymic lymphomas from 10wk old p53 deficient mice with p63 or p73 conditional knockout
T29 IKAROS1-deficient thymic lymphoma cells expressing tamoxifen-inducible IKAROS1
T29 IKAROS1-deficient thymic lymphoma cells expressing dominant-negative MASTERMIND
Explore Curated Studies Results
Literature
Most Relevant Literature
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatri…
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma.
Correlation of the surface expression of thymic stromal lymphopoietin receptor with the presence of …
Ectopic Cervical Thymic Hyperplasia In A Patient Treated For Hodgkin Lymphoma.
Alcohol-driven metabolic reprogramming promotes development of RORĪ³t-deficient thymic lymphoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study on Proton Radiotherapy of Thymic Malignancies
Pembrolizumab and Vorinostat in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell L…
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma
Risk Adapted Therapy in Diffuse Large B Cell Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ